BMRN vs DOC · P/E 40, rev $2.85B vs P/E 62, rev $2.70B
Biomarin Pharmaceutical Inc (BMRN) versus Healthpeak Properties Inc (DOC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Healthpeak Properties Inc (DOC) is a reit - healthcare facilities company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DOC revenue for 2024-12-31 was $2.70B. Net income was $267.3M. Revenue was up 23.8% from 2023-12-31 to 2024-12-31. DOC currently screens at market cap $13.64B and trailing P/E 61.8.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DOC currently screens at market cap $13.64B and trailing P/E 61.8.
Not investment advice. Open the BMRN and DOC stock pages for the full models.
Not investment advice.